Predictions

Research grant management to increase transparency

Future considerations in grant management schemes

Today, there is a strong need to increase transparency in collaborative activities between pharmaceutical companies and academia, including the use of such grants.

Explore content

Research grant management scheme

Historically in Japan, funding to academia for medical and pharmaceutical research has been made by the private sector, such as pharmaceutical companies, with research grants accounting for largest proportion. Today, there is a strong need to increase transparency in collaborative activities between pharmaceutical companies and academia, including the use of such grants. This paper discusses future considerations in grant management schemes based on Deloitte’s knowledge on the current situation for pharmaceutical companies in Japan. 

(351KB,PDF)
Did you find this useful?